By Paul Deckelman
New York, March 22 - Aviv REIT, Inc. came to market on Tuesday with an opportunistically timed and rapidly marketed $100 million add-on (expected B1/B+) to its existing 7¾% senior notes due 2019, which the Chicago-based health care facilities owner had sold in January.
The deal priced several hours after its initial announcement and was upsized from the initially planned $75 million. The notes priced at 102.75, at the tight end of price talk envisioning a range between 102.5 and 102.75.
The yield to maturity was 7.163%.
The Rule 144A/Regulation S transaction came to market via joint bookrunning managers Merrill Lynch, Morgan Stanley & Co. Inc. and RBC Capital Markets LLC.
Citigroup Global Markets Inc. and Stifel, Nicolaus & Co. Inc. were the co-managers on the deal.
The bonds will carry four years of call protection and will be considered part of the same series as the $200 million of 7¾% bonds sold at par in January. The notes were formally issued by Aviv subsidiaries Aviv Healthcare Properties LP and Aviv Healthcare Capital Corp.
The company plans to use $36 million of the deal proceeds to repay a portion of its secured debt, with the balance of about $64 million to be used to fund the debt component of $110 million of pending investments.
Issuers: | Aviv REIT, Inc. via subsidiaries Aviv Healthcare Properties LP and Aviv Healthcare Capital Corp.
|
Amount: | $100 million, upsized from $75 million
|
Maturity | Feb. 15, 2019
|
Securities: | Add-on senior notes
|
Bookrunners: | Merrill Lynch, Morgan Stanley & Co. Inc. and RBC Capital Markets LLC.
|
Co-managers: | Citigroup Global Markets Inc. and Stifel, Nicolaus & Co. Inc.
|
Coupon: | 7¾%
|
Price: | 102.75
|
Yield: | 7.163%
|
Spread: | 442 bps over 2¾% UST due Feb. 15, 2019
|
Call features: | Make-whole call at T+50 bps until Feb. 15, 2015, then callable at a premium
|
Equity clawback: | For up to 35% of the issue at 107.75 until Feb. 15, 2014
|
Change of Control: | Put at 101% of principal plus accrued interest
|
Trade date: | March 22
|
Settlement date: | April 5 (T+10)
|
Expected : | Moody's: B1
|
| Standard & Poor's: B+
|
Distribution: | Rule 144A/Regulation S
|
Price talk: | 102.5-102.75
|
Marketing: | Quick-to-market
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.